Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Y Chan

Showing results (101-110 of 214) with videos related to

Pageof 22
Sort By:
Cardiovascular Research|March 5, 2019
Toll-like receptor 7 deficiency promotes survival and reduces adverse left ventricular remodelling after myocardial infarctionDominique P V de Kleijn, Suet Yen Chong, Xiaoyuan Wang, et al.
Expert Review of Molecular Diagnostics|November 5, 2015
The diagnostic and prognostic potential of plasma extracellular vesicles for cardiovascular diseaseIngrid E M Bank, Leo Timmers, Crystel M Gijsberts, et al.
Journal of Thrombosis and Thrombolysis|February 21, 2020
Patients with acute and chronic coronary syndromes have elevated long-term thrombin generationChristina Yip, Aruni Seneviratna, Sock-Hwee Tan, et al.
Cell Reports. Medicine|July 1, 2021
Differential modulation of polyunsaturated fatty acids in patients with myocardial infarction treated with ticagrelor or clopidogrelKarla N Samman, Pamela Mehanna, Emad Takla, et al.
European Journal of Clinical Pharmacology|January 28, 2014
Safety of combination therapy with milrinone and esmolol for heart protection during percutaneous coronary intervention in acute myocardial infarctionKian-Keong Poh, Xin Xu, Mark Y Chan, et al.
Journal of Thrombosis and Thrombolysis|August 3, 2012
Angiographic and platelet reactivity outcomes with prasugrel 60 mg pretreatment and clopidogrel 600 mg pretreatment in primary percutaneous coronary interventionYiding Li, Bee-Choo Tai, Winnie Sia, et al.
Sleep|January 31, 2025
Patient-Reported Quality of Life Outcomes with Mandibular Advancement versus CPAP: Insights from the CRESCENT TrialJuliana Tereza Colpani, Yi-Hui Ou, Annushiah Vasan Thakumar, et al.
Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography|April 19, 2021
Association of Global Cardiac Calcification with Atrial Fibrillation and Recurrent Stroke in Patients with Embolic Stroke of Undetermined SourceTony Y W Li, Leonard L L Yeo, Jamie S Y Ho, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|April 24, 2021
Long-Term Clinical Outcomes of Biodegradable-Polymer Drug-Eluting Stents Versus Second-Generation Durable-Polymer Drug-Eluting Stents for ST-Segment Elevation Myocardial InfarctionHui Wen Sim, Elizabeth H Thong, Andie H Djohan, et al.
European Heart Journal. Quality of Care & Clinical Outcomes|September 15, 2022
Meta-analysis of the Placebo and Nocebo effects associated with Placebo treatment in randomized trials of lipid-lowering therapiesYip H Chin, Oliver Lim, Chaoxing Lin, et al.
Pageof 22

Showing results (101-110 of 214) with videos related to

Sort By:
Pageof 22
Cardiovascular Research|March 5, 2019
Toll-like receptor 7 deficiency promotes survival and reduces adverse left ventricular remodelling after myocardial infarctionDominique P V de Kleijn, Suet Yen Chong, Xiaoyuan Wang, et al.
Expert Review of Molecular Diagnostics|November 5, 2015
The diagnostic and prognostic potential of plasma extracellular vesicles for cardiovascular diseaseIngrid E M Bank, Leo Timmers, Crystel M Gijsberts, et al.
Journal of Thrombosis and Thrombolysis|February 21, 2020
Patients with acute and chronic coronary syndromes have elevated long-term thrombin generationChristina Yip, Aruni Seneviratna, Sock-Hwee Tan, et al.
Cell Reports. Medicine|July 1, 2021
Differential modulation of polyunsaturated fatty acids in patients with myocardial infarction treated with ticagrelor or clopidogrelKarla N Samman, Pamela Mehanna, Emad Takla, et al.
European Journal of Clinical Pharmacology|January 28, 2014
Safety of combination therapy with milrinone and esmolol for heart protection during percutaneous coronary intervention in acute myocardial infarctionKian-Keong Poh, Xin Xu, Mark Y Chan, et al.
Journal of Thrombosis and Thrombolysis|August 3, 2012
Angiographic and platelet reactivity outcomes with prasugrel 60 mg pretreatment and clopidogrel 600 mg pretreatment in primary percutaneous coronary interventionYiding Li, Bee-Choo Tai, Winnie Sia, et al.
Sleep|January 31, 2025
Patient-Reported Quality of Life Outcomes with Mandibular Advancement versus CPAP: Insights from the CRESCENT TrialJuliana Tereza Colpani, Yi-Hui Ou, Annushiah Vasan Thakumar, et al.
Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography|April 19, 2021
Association of Global Cardiac Calcification with Atrial Fibrillation and Recurrent Stroke in Patients with Embolic Stroke of Undetermined SourceTony Y W Li, Leonard L L Yeo, Jamie S Y Ho, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|April 24, 2021
Long-Term Clinical Outcomes of Biodegradable-Polymer Drug-Eluting Stents Versus Second-Generation Durable-Polymer Drug-Eluting Stents for ST-Segment Elevation Myocardial InfarctionHui Wen Sim, Elizabeth H Thong, Andie H Djohan, et al.
European Heart Journal. Quality of Care & Clinical Outcomes|September 15, 2022
Meta-analysis of the Placebo and Nocebo effects associated with Placebo treatment in randomized trials of lipid-lowering therapiesYip H Chin, Oliver Lim, Chaoxing Lin, et al.
Pageof 22